Упрощенная HTML-версия
128. BuzzeIli G. A pilot study on the liver protective effect of silybin-phosphatidyl-
choline complex (1dB 1016) in chronic active hepatitis / G. BuzzeIli, S. Moscarella, A. Guisti et al.
// Int. J. Clin. Pharmacol. Ther. Toxicol. —1993. —№ 31. —P.456—460.
129. Capel J.D. Hepatic function assessed (in rats) during chemotherapy with some anti-
cancer drugs / J.D. Capel, M. Jenner, H.M. Dorrell, D.C. Williams // Clin. Chem. — 1979. — Vol.
25, Na 8.—P. 138 1—1383.
130. Carini R. Lipid peroxidation and irreversible damage in the rat hepatocyte model.
Protection by the silybin-phospholipid complex 1dB 1016 / R. Carini, A. Comoglio, E. Albano, G.
Poll // Biohem. Pharmacol. — 1992. — Na 28. — P. 2111—2115.
131. Chrungoo V. Differential biochemical reponse of freshly isolated rat hepatocytes to
paracetamol, carbon tetrachloride and D-galactosamine toxicity / V. Chrungoo, K. Singh, J. Singh //
Indian J. Exp Biol. — 1997. — Vol. 35. №6.—P. 603—610.
132. Chwiecko M. Inhibition of non-enzymatic lipid peroxidation by essentiale, a drug
enriched in phosphatidyicholine in ethanol-induced liver injury / M. Chwiecko, A. Holownia, A.
Bielawska, R. Farbiszewski // Drug Alcohol. Depend. — 1993. — Vol. 33,№ 1. — P. 87—93.
133. Cleland B.D. Cyclophosphamide related hepatotoxicity / B.D. Cleland, C.S. Pokorny
// Aust. N. Z. J. Med. — 1993. — Vol. 23, №4. — P. 408.
134. Cohn L. Glucocorticosteroids as immunosuppressive agents // Semin. Vet. Med.
Surg. (Small Anim.) — 1997. — Vol. 12, № 3. — P. 150—156.
135. Conti M. Protective activity of silipide on the liver damage in rodents/ M. Conti, S.
Malandrino, M. Magistretti // Jpn. J. Pharmacol. — 1992.—№ 4. — P. 3 15—321.
136. Diaz-Buxo J. Gal actosamine-induced fulminant hepatic necrosis in unanesthetized
canines / J. Diaz-Buxo, S. Blumenthal, D. Hayes // Hepatology. — 1997. — Vol. 25, Na 4. — P.
950—957.
137. Elenkov I. Stress, corticotropin-releasing hormone, glucocorticoids and the
immune/inflammatory response: acute end chronic effects / I. Elenkov, E. Webster, D. Torpy // Ana.
N.Y. Acad. Sci. — 1999. — Vol. 876, № 22.—P. 1—11.
138. Franke H. Short-term effect of carbon tetrachloride on the lipoprotein secretion in
isolated rat hepatocytes / H. Franke, G. Poll, T. Zimmermann // Wirchows Arch. — 1988. — Bd. 4,
№ 2. —5. 357—365.
139. Fromenty F. Microvesicular steatosis and steatohepatitis: role of mitochondrial
dysfunction and lipid peroxidation / F. Fromenty, A. Berson, D. Pessayre // J. Hepatol. — 1997.—
Vol. 26, Suppl. I. — P. 13—22.
140. Gebharr A. Carbon tetrachloride depresses hepatic phospholipid synthesis in rats / A.
Gebharr, M. Brabec // Toxicol. Lett. — 1985. — Vol. 24, № 1. — p. 71—78.
141. Giacomelli S. Silybin and its bioavailable phospholipid complex (idBl016) potentiale
in vitro and in vivo the activity of cisplatin / S. Giacomelli, D. Gallo, P. Apollonio //Life Sci. —
2002. —№ 12.—P. 1447—1459.
142. Gismondi C. Hepatotoxicity of cyclophosphamide in the rat after prolonged
treatment: a histomorphological study / C. Gismondi, L. Dabove, M. Dovi // Boll. Soc. Ital. Biol.
Sper.— 1980.—Vol. 56, № 21.—P. 2166—2172.
143. Goldberg J.W. Cyclophosphamide-associated hepatotoxicity / J.W. Goldberg, M.D.
Lidsky // South. Med. J. — 1985. — Vol. 78, № 2. — P. 222—223.
144. Gurroo H.L. Role of glutathione in the metabolism-dependent toxicity and
chemotherapy of cyclophosphamide / H.L. Gurroo, J.H. Hipkens, S.D. Sharma // Cancer. Res. —
1981.—Vol. 41, № 9, Pt.1. —P.3584-3591.
145. Honjo I. Hepatotoxicity of cyclophosphamide in man: pharmacokinetic analysis / I.
Honjo, T. Suou, C.Hirayaina // Res. Comniun. Chem. Pathol. Pharmacol. — 1988. — Vol. 61, №
2.—P. 149—165.